Literature DB >> 34359615

Primary Aldosteronism: Metabolic Reprogramming and the Pathogenesis of Aldosterone-Producing Adenomas.

Siyuan Gong1, Martina Tetti1,2, Martin Reincke1, Tracy Ann Williams1,2.   

Abstract

Aldosterone-producing adenomas (APAs) are characterized by aldosterone hypersecretion and deregulated adrenocortical cell growth. Increased energy consumption required to maintain cellular tumorigenic properties triggers metabolic alterations that shape the tumor microenvironment to acquire necessary nutrients, yet our knowledge of this adaptation in APAs is limited. Here, we investigated adrenocortical cell-intrinsic metabolism and the tumor immune microenvironment of APAs and their potential roles in mediating aldosterone production and growth of adrenocortical cells. Using multiple advanced bioinformatics methods, we analyzed gene expression datasets to generate distinct metabolic and immune cell profiles of APAs versus paired adjacent cortex. APAs displayed activation of lipid metabolism, especially fatty acid β-oxidation regulated by PPARα, and glycolysis. We identified an immunosuppressive microenvironment in APAs, with reduced infiltration of CD45+ immune cells compared with adjacent cortex, validated by CD45 immunohistochemistry (3.45-fold, p < 0.001). APAs also displayed an association of lipid metabolism with ferroptosis and upregulation of antioxidant systems. In conclusion, APAs exhibit metabolic reprogramming towards fatty acid β-oxidation and glycolysis. Increased lipid metabolism via PPARα may serve as a key mechanism to modulate lipid peroxidation, a hallmark of regulated cell death by ferroptosis. These findings highlight survival advantages for APA tumor cells with metabolic reprogramming properties.

Entities:  

Keywords:  PPARα; adaptive metabolism; adrenal gland; conn adenoma; fatty acid metabolism; ferroptosis; hyperaldosteronism; metabolic reprogramming; tumor microenvironment; β-oxidation

Year:  2021        PMID: 34359615     DOI: 10.3390/cancers13153716

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  4 in total

1.  Hypomethylation associated vitamin D receptor expression in ATP1A1 mutant aldosterone-producing adenoma.

Authors:  Yuta Nanao; Kenji Oki; Kazuhiro Kobuke; Kiyotaka Itcho; Ryuta Baba; Takaya Kodama; Yu Otagaki; Akira Okada; Yoko Yoshii; Gaku Nagano; Haruya Ohno; Koji Arihiro; Celso E Gomez-Sanchez; Noboru Hattori; Masayasu Yoneda
Journal:  Mol Cell Endocrinol       Date:  2022-03-04       Impact factor: 4.369

2.  ATP1A1 Mutant in Aldosterone-Producing Adenoma Leads to Cell Proliferation.

Authors:  Kazuhiro Kobuke; Kenji Oki; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez; Kiyotaka Itcho; Haruya Ohno; Gaku Nagano; Yoko Yoshii; Ryuta Baba; Takaya Kodama; Koji Arihiro; Noboru Hattori; Masayasu Yoneda
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

3.  New Insights in the Genetics and Genomics of Adrenocortical Tumors and Pheochromocytomas.

Authors:  Peter Igaz
Journal:  Cancers (Basel)       Date:  2022-02-21       Impact factor: 6.639

Review 4.  Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation.

Authors:  Martina Tetti; Siyuan Gong; Franco Veglio; Martin Reincke; Tracy Ann Williams
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.